A 68-year-old man presents to the clinic with a 4-day history of increased cough, increase… — USMLE Step 3

A 68-year-old man presents to the clinic with a 4-day history of increased cough, increased sputum volume that has become markedly purulent, and worsening dyspnea. He has a past medical history of severe chronic obstructive pulmonary disease (COPD), hyperlipidemia, and paroxysmal atrial fibrillation. His current daily medications include a tiotropium inhaler, a formoterol inhaler, simvastatin, and sotalol. Vital signs show a temperature of $37.5^\circ\text{C}$ ( $99.5^\circ\text{F}$ ), blood pressure of $135/85\text{ mmHg}$ , heart rate of $76/\text{min}$ , and respiratory rate of $22/\text{min}$ . Oxygen saturation is $92\%$ on room air. Pulmonary auscultation reveals a prolonged expiratory phase with diffuse bilateral wheezing. Laboratory studies show a leukocyte count of $8,500/\mu L$ and a serum creatinine of $1.0\text{ mg/dL}$ . An electrocardiogram obtained in the clinic demonstrates normal sinus rhythm with a corrected QT (QTc) interval of $535\text{ ms}$ . The physician plans to prescribe a 5-day course of oral prednisone and optimize the patient's bronchodilator therapy. Which of the following is the most appropriate antimicrobial approach for this patient?

Initiate oral doxycyclineAnswer
B
Initiate oral azithromycin
C
Initiate oral clarithromycin
D
Initiate oral amoxicillin
E
Withhold antimicrobial therapy due to the normal leukocyte count

Answer

The most appropriate approach is to initiate oral doxycycline because it safely covers the expected respiratory pathogens without exacerbating the patient's significantly prolonged QTc interval or interacting with his statin therapy.

The correct approach is to initiate oral doxycycline. This patient presents with an acute exacerbation of COPD meeting all three cardinal Anthonisen criteria (increased dyspnea, increased sputum volume, and increased sputum purulence), which establishes a clear clinical indication for empiric antibiotic therapy. The standard empiric options include macrolides (e.g., azithromycin), respiratory fluoroquinolones (e.g., levofloxacin), doxycycline, or amoxicillin-clavulanate. However, this patient has a baseline QTc interval of 535 ms and is taking sotalol (a Class III antiarrhythmic). A QTc interval greater than 500 ms is a strict absolute contraindication to the use of QT-prolonging medications (including all macrolides and fluoroquinolones) due to the high risk of Torsades de Pointes and sudden cardiac death. Doxycycline provides excellent coverage against the primary respiratory pathogens (Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis) and atypical organisms, without affecting the QT interval or interacting with his statin therapy.

Step-by-Step Solution

Evaluate the indication for antibiotics in this patient's acute COPD exacerbation.

The patient has three cardinal symptoms: increased dyspnea, increased sputum volume, and increased sputum purulence.

According to the Anthonisen criteria, antibiotics are indicated when all three cardinal symptoms are present, or when two are present and one of them is increased purulence. A normal leukocyte count does not negate this strong clinical indication.

Identify the common pathogens responsible for COPD exacerbations to determine the required empiric coverage.

Therapy must cover Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae, as well as atypical organisms.

Empiric therapy needs to be broad enough to cover typical bacterial pathogens (many of which produce beta-lactamases) and atypical pathogens.

Assess the patient's current medication list and electrocardiogram for absolute contraindications and severe drug-drug interactions.

The patient is taking sotalol and simvastatin, and has a significantly prolonged baseline QTc interval of 535 ms.

Sotalol is a Class III antiarrhythmic that prolongs the QT interval. A QTc > 500 ms poses a high risk for Torsades de Pointes, making any additional QT-prolonging drugs (such as macrolides or fluoroquinolones) absolutely contraindicated. Furthermore, simvastatin is metabolized by CYP3A4, requiring the avoidance of strong CYP3A4 inhibitors.

Select the antimicrobial agent that meets all safety and efficacy criteria for this specific patient.

Doxycycline is selected.

Doxycycline provides appropriate antimicrobial coverage, does not prolong the QT interval, and does not inhibit CYP3A4, making it the safest and most effective choice.

Key Concept

In patients with acute COPD exacerbations meeting clinical criteria for antibiotics, the choice of agent must account for underlying comorbidities and drug interactions, specifically avoiding QT-prolonging macrolides or fluoroquinolones in patients with a prolonged baseline QTc interval.

Estimated Time:1m 30s

Question

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Topics

More questions from this topic